FORA Forian Inc.

Nasdaq forian.com


$ 2.09 $ 0.00 (0 %)    

Friday, 17-Oct-2025 06:46:33 EDT
QQQ $ 599.10 $ 0.00 (0 %)
DIA $ 460.50 $ 0.00 (0 %)
SPY $ 660.88 $ 0.00 (0 %)
TLT $ 91.15 $ 0.00 (0 %)
GLD $ 395.45 $ 0.00 (0 %)
$ 2.18
$ 2.20
$ 2.09 x 1
$ 2.20 x 87
-- - --
$ 1.64 - $ 4.03
118,389
na
nm
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-11-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 forian-receives-unsolicited-proposal-from-ceo-to-be-taken-private

https://www.newmediawire.com/news/forian-receives-unsolicited-proposal-from-ceo-to-be-taken-private-7082169

 forian-q2-eps-001-beats-004-estimate-sales-7476m-beat-7166m-estimate

Forian (NASDAQ:FORA) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.04) by 125...

 roth-mkm-reiterates-buy-on-forian-maintains-5-price-target

Roth MKM analyst Richard Baldry reiterates Forian (NASDAQ:FORA) with a Buy and maintains $5 price target.

 forian-q3-eps-001-beats-003-estimate-sales-469m-miss-481m-estimate

Forian (NASDAQ:FORA) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66....

 earnings-preview-forian
Earnings Preview: Forian
11/12/2024 18:07:29

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION